INTRODUCTION
Hepatic hemangioma is the most common benign tumor of the liver. Recently its frequency of detection has increased with the introduction of nation-wide cancer screening programs and technical improvement of radiological modalities such as computed tomography (CT) and ultrasonography. Radiological findings of typical hemangioma are well-known. However, sometimes, there are some atypical findings of hemangioma due to complications such as thrombosis, infarction, hemorrhage or sclerosis.
1,2 Therefore, they can be frequently misdiagnosed and confused with other malignant hepatic tumors.
In this report, a case of sclerosing hepatic hemangioma is presented with radiological findings.
CASE
A 50-year-old male was admitted with the complaint of an incidentally detected liver mass. He has lost 6 kg weight during recent 2 months, so he took precise health examination, and he was diagnosed as diabetes mellitus. Also a large hepatic mass was detected on abdominal CT scan. He did not present specific symptoms such as abdominal pain or anorexia. Physical examination revealed no specific findings such as hepatomegaly, either.
The laboratory findings showed red blood cell count of Total bilirubin was 0.8 mg/dL. Alpha-fetoprotein was 2 ng/mL, and carcinoembryonic antigen was 0.79 ng/mL. The results for hepatitis B surface (HBs) antigen and anti-HBs were negative.
Ultrasonography showed large liver mass in right lobe (Fig. 1 ).
It showed well marginated mass with internally heterogeneous mixed echo containing echogenic area and hypoechoic area. CT showed 10 cm sized and irregular homogenously low attenuated round masses in the liver on precontrast scan ( Seoul, Korea), and images were taken at 10, 50 and 300 seconds after contrast injection. On T2-weighted image, the mass showed diffuse homogenous high signal intensity including the central area which was not enhanced on delayed phase contrastenhanced scan (Fig. 3E) . The Central unenhanced area was suggested as sclerotic mesenchyma, not necrosis.
Fluorodexoyglucose positron emission tomography (FDG-PET) scan showed iso-to hypometabolic mass in right lobe of the liver (Fig. 4) .
The mass was radiologically diagnosed as sclerosing hemangioma. highly reliable for diagnosis, especially MRI, which has a sensitivity and specificity of >90%. However, only about 50% of all hemangiomas show these typical radiological findings. 4 The diagnosis of some atypical hemangiomas remains uncertain with an MRI study owing to the presence of intralesional thrombosis or calcified, hyalinized, or cystic components that result in the loss of its characteristic appearance of markedly high signal intensity on heavy T2-weighted imaging and present with atypical enhancement patterns on postenhanced study. 5 In these cases, it can lead to misdiagnosis and confusion with other hepatic tumors including malignant tumor. So, these cases require biopsy and histopathological examination. It has been postulated that central non-opaicified areas might be related to slow blood flow in the central sinusoids, necrosis, fibrosis, central thrombosis, or hemorrhage. 4 In another report, consistent low attenuation on unenhanced and dynamic CT scans and bright high signal intensity on T2 weighted MR images, was pathologically composed of a hyalinized portion. 5 It is particularly important that CT appearances of sclerotic nodule in hepatic hemangioma might be confused with other malignant tumors with necrosis. 4 However, in our case, there was unenhanced area on delayed phase scan, but it did not present more hypoattenuated area on unenhanced scan nor higher signal intensity areas on T2
weighted MR images, so it was postulated as sclerosing mesenchyma with very slow contrast enhancement, not hyalinized area.
In conclusion, although sclerosis and other pathological complications are rare in hepatic hemangiomas, an awareness of this complication and an understanding of the pathological background of its atypical radiological appearances are important.
Percutaneous biopsy may make unnecessary surgery avoidable.
SUMMARY
In the present case above, the mass showed high signal intensity on T-2 weighted images as like typical hemangioma. However, typical peripheral nodular enhancement was not seen and there was central unenhanced low attenuated area until delayed phase on CT and MRI, so sclerosing hemangioma was suspected. To differentiate from other hepatic tumors, biopsy was done, and pathologically sclerosing hemangioma was confirmed.
